Consistent with our findings, JAK/STAT signaling has recently been shown to initiate lineage plasticity in prostate cancer as well as to promote lineage plasticity–driven targeted therapy resistance in a stem-like subpopulation of prostate cancer (82, 83). The gene discussed is SOAT1; the disease is prostate cancer.